Skin Cancer Drug Reverses Alzheimer's Symptoms In Mice
An anonymous reader writes "A skin cancer drug may rapidly reverse pathological, cognitive and memory deterioration associated with Alzheimer's disease, according to new research published on Thursday. Bexarotene, a drug that is currently used to combat T cell lymphoma, appeared to reverse plaque buildup and improve memory in the brains of mice with Alzheimer's disease by reducing levels of beta-amyloid plaques in the brain that cause mental deficits in Alzheimer's disease."
but I forgot what we were talking about
RTECS No: not available
Acute toxicity: oral toxicity (LD50): >1500 mg/kg (rat); >720 mg/kg (dog)
Dermal NOEL: 0.01% (rat)
Primary irritant effect:
On the skin: not known; may be an irritant; exposure may exacerbate the deleterious effects of sunlight
On the eye: not known; may be an irritant
Ingestion: may cause effects similar to hypervitaminosis A including headache, nausea, vomiting, lip inflammation, mucous membrane dryness, joint pain, scaly skin, and hyperlipidemia
---
Yeah. I'd still take it.
Lots of outlets are publishing this, one of the more interesting ones was CNN's: http://www.cnn.com/2012/02/09/health/us-cancer-drug-alzheimers/index.html?hpt=he_c2
Check out the quote: "We've fixed Alzheimer's in mice lots of times, so we need to move forward expeditiously but cautiously."
So, would it be safe to say that Alzheimer's in mice is different from that in humans (on some level) so you might want to wait a bit before overdosing on Skin Cancer meds?
myke
Mimetics Inc. Twitter
My father was diagnosed with Alzheimer's three years ago. It is simply brutal to see what this disease does to the people you love. But given the inevitable outcome of Alzheimer's, I'll grasp at any straw I can find if it presents some remote hope of a different outcome. This kind of perspective can't help but make one feel as if you're vulnerable to hucksters. There have been similar claims about more dubious Alzheimer's treatments, such as coconut oil, but when it comes down to it my approach is "Will it kill him or hurt him? If not, then let's try it, what have we got to lose."
The human testing and approval process for treating Alzheimer's with bexarotene will simply take too long to be of any benefit to him. I want to get a physician to approve this medication for the off-label use for my father, so we can try it on him.
I hope it is not reckless nor irresponsible to see if I can use my father as a sort of non-controlled subject for this study. But it seems that I have the choice between (1) risking a negative, possibly fatal or crippling, reaction for a remote chance at reversing a fatal, painful disease, or (2) waiting responsibly for the gears of formal human medical approval turn, test, find that this works, and approve prescribing it for patients. What kind of a choice is that?
No problem, they'll just go off and live with the rats of NIMH.
Just a week ago, the Slashdot item Alzheimer's Transmission Pathway Discovered reported that Alzheimer was caused by the spread of the tau protein gone wrong. How is this to be interpretted in the view of the above new item?